Literature DB >> 26292315

Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study.

Madoka Kuramitsu1, Kazu Okuma1, Tadanori Yamochi2, Tomoo Sato3, Daisuke Sasaki4, Hiroo Hasegawa4, Kazumi Umeki5, Ryuji Kubota6, Rieko Sobata7, Chieko Matsumoto7, Noriaki Kaneko8, Isao Naruse8, Makoto Yamagishi2, Makoto Nakashima2, Haruka Momose1, Kumiko Araki1, Takuo Mizukami1, Saeko Mizusawa1, Yoshiaki Okada1, Masaki Ochiai9, Atae Utsunomiya10, Ki-Ryang Koh11, Masao Ogata12, Kisato Nosaka13, Kaoru Uchimaru14, Masako Iwanaga15, Yasuko Sagara16, Yoshihisa Yamano3, Masahiro Satake7, Akihiko Okayama5, Manabu Mochizuki17, Shuji Izumo6, Shigeru Saito18, Kazuo Itabashi19, Shimeru Kamihira20, Kazunari Yamaguchi1, Toshiki Watanabe2, Isao Hamaguchi21.   

Abstract

Quantitative PCR (qPCR) analysis of human T-cell leukemia virus type 1 (HTLV-1) was used to assess the amount of HTLV-1 provirus DNA integrated into the genomic DNA of host blood cells. Accumulating evidence indicates that a high proviral load is one of the risk factors for the development of adult T-cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis. However, interlaboratory variability in qPCR results makes it difficult to assess the differences in reported proviral loads between laboratories. To remedy this situation, we attempted to minimize discrepancies between laboratories through standardization of HTLV-1 qPCR in a collaborative study. TL-Om1 cells that harbor the HTLV-1 provirus were serially diluted with peripheral blood mononuclear cells to prepare a candidate standard. By statistically evaluating the proviral loads of the standard and those determined using in-house qPCR methods at each laboratory, we determined the relative ratios of the measured values in the laboratories to the theoretical values of the TL-Om1 standard. The relative ratios of the laboratories ranged from 0.84 to 4.45. Next, we corrected the proviral loads of the clinical samples from HTLV-1 carriers using the relative ratio. As expected, the overall differences between the laboratories were reduced by half, from 7.4-fold to 3.8-fold on average, after applying the correction. HTLV-1 qPCR can be standardized using TL-Om1 cells as a standard and by determining the relative ratio of the measured to the theoretical standard values in each laboratory.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26292315      PMCID: PMC4609719          DOI: 10.1128/JCM.01628-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.

Authors:  Helen E White; Paul Matejtschuk; Peter Rigsby; Jean Gabert; Feng Lin; Y Lynn Wang; Susan Branford; Martin C Müller; Nathalie Beaufils; Emmanuel Beillard; Dolors Colomer; Dana Dvorakova; Hans Ehrencrona; Hyun-Gyung Goh; Hakim El Housni; Dan Jones; Veli Kairisto; Suzanne Kamel-Reid; Dong-Wook Kim; Stephen Langabeer; Edmond S K Ma; Richard D Press; Giuliana Romeo; Lihui Wang; Katerina Zoi; Timothy Hughes; Giuseppe Saglio; Andreas Hochhaus; John M Goldman; Paul Metcalfe; Nicholas C P Cross
Journal:  Blood       Date:  2010-08-18       Impact factor: 22.113

2.  De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.

Authors:  Paola Miyazato; Jun-ichirou Yasunaga; Yuko Taniguchi; Yoshio Koyanagi; Hiroaki Mitsuya; Masao Matsuoka
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count.

Authors:  S Kamihira; N Dateki; K Sugahara; T Hayashi; H Harasawa; S Minami; Y Hirakata; Y Yamada
Journal:  Clin Lab Haematol       Date:  2003-04

4.  Intra- and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: a multi-center study.

Authors:  Shimeru Kamihira; Yoshihisa Yamano; Masako Iwanaga; Daisuke Sasaki; Masahiro Satake; Akihiko Okayama; Kazumi Umeki; Ryuji Kubota; Shuji Izumo; Kazunari Yamaguchi; Toshiki Watanabe
Journal:  Cancer Sci       Date:  2010-09-28       Impact factor: 6.716

5.  Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1.

Authors:  R Sobata; C Matsumoto; S Uchida; Y Suzuki; M Satake; K Tadokoro
Journal:  Vox Sang       Date:  2015-04-30       Impact factor: 2.144

6.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.

Authors:  Masako Iwanaga; Toshiki Watanabe; Atae Utsunomiya; Akihiko Okayama; Kaoru Uchimaru; Ki-Ryang Koh; Masao Ogata; Hiroshi Kikuchi; Yasuko Sagara; Kimiharu Uozumi; Manabu Mochizuki; Kunihiro Tsukasaki; Yoshio Saburi; Masaomi Yamamura; Junji Tanaka; Yukiyoshi Moriuchi; Shigeo Hino; Shimeru Kamihira; Kazunari Yamaguchi
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

7.  Real-time polymerase chain reaction for quantification of HTLV-1 proviral load: application for analyzing aberrant integration of the proviral DNA in adult T-cell leukemia.

Authors:  S Kamihira; N Dateki; K Sugahara; Y Yamada; M Tomonaga; T Maeda; M Tahara
Journal:  Int J Hematol       Date:  2000-07       Impact factor: 2.490

8.  Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.

Authors:  Masahiro Satake; Kazunari Yamaguchi; Kenji Tadokoro
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

9.  Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.

Authors:  K Sugamura; M Fujii; M Kannagi; M Sakitani; M Takeuchi; Y Hinuma
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

Review 10.  Current status of HTLV-1 infection.

Authors:  Toshiki Watanabe
Journal:  Int J Hematol       Date:  2011-10-04       Impact factor: 2.319

View more
  9 in total

1.  Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Authors:  Madoka Kuramitsu; Tsuyoshi Sekizuka; Tadanori Yamochi; Sanaz Firouzi; Tomoo Sato; Kazumi Umeki; Daisuke Sasaki; Hiroo Hasegawa; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Haruka Momose; Kumiko Araki; Masumichi Saito; Kisato Nosaka; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Akihiko Okayama; Kiyonori Miura; Masahiro Satake; Shigeru Saito; Kazuo Itabashi; Kazunari Yamaguchi; Makoto Kuroda; Toshiki Watanabe; Kazu Okuma; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

2.  Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia.

Authors:  Sanaz Firouzi; Amir Farmanbar; Kenta Nakai; Masako Iwanaga; Kaoru Uchimaru; Atae Utsunomiya; Yutaka Suzuki; Toshiki Watanabe
Journal:  Blood Adv       Date:  2017-06-27

3.  Transition of adult T-cell leukemia/lymphoma clones during clinical progression.

Authors:  Sakura Aoki; Sanaz Firouzi; Yosvany López; Tadanori Yamochi; Kazumi Nakano; Kaoru Uchimaru; Atae Utusnomiya; Masako Iwanaga; Toshiki Watanabe
Journal:  Int J Hematol       Date:  2016-07-06       Impact factor: 2.490

4.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

5.  Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR.

Authors:  Evandra Strazza Rodrigues; Suellen Salustiano; Elaine Vieira Santos; Svetoslav Nanev Slavov; Virgínia Picanço-Castro; Juliana Matos Maçonetto; Tissiana Marques de Haes; Osvaldo Massaiti Takayanagui; Dimas Tadeu Covas; Simone Kashima
Journal:  J Neurovirol       Date:  2022-01-13       Impact factor: 2.643

6.  RAISING is a high-performance method for identifying random transgene integration sites.

Authors:  Yusaku Wada; Tomoo Sato; Hiroo Hasegawa; Takahiro Matsudaira; Naganori Nao; Ariella L G Coler-Reilly; Tomohiko Tasaka; Shunsuke Yamauchi; Tomohiro Okagawa; Haruka Momose; Michikazu Tanio; Madoka Kuramitsu; Daisuke Sasaki; Nariyoshi Matsumoto; Naoko Yagishita; Junji Yamauchi; Natsumi Araya; Kenichiro Tanabe; Makoto Yamagishi; Makoto Nakashima; Shingo Nakahata; Hidekatsu Iha; Masao Ogata; Masamichi Muramatsu; Yoshitaka Imaizumi; Kaoru Uchimaru; Yasushi Miyazaki; Satoru Konnai; Katsunori Yanagihara; Kazuhiro Morishita; Toshiki Watanabe; Yoshihisa Yamano; Masumichi Saito
Journal:  Commun Biol       Date:  2022-06-02

7.  Genetic diversity of STLV-2 and interspecies transmission of STLV-3 in wild-living bonobos.

Authors:  Steve Ahuka-Mundeke; Octavie Lunguya-Metila; Valentin Mbenzo-Abokome; Christelle Butel; Bila-Isia Inogwabini; Valentin Omasombo; Jean-Jacques Muyembe-Tamfum; Alexander V Georgiev; Martin N Muller; Jean-Bosco N Ndjango; Yingying Li; Eric Delaporte; Beatrice H Hahn; Martine Peeters; Ahidjo Ayouba
Journal:  Virus Evol       Date:  2016-05-25

8.  Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Authors:  Carolina Rosadas; Carlos Brites; Denise Arakaki-Sanchez; Jorge Casseb; Ricardo Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

9.  Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

Authors:  Kazu Okuma; Madoka Kuramitsu; Toshihiro Niwa; Tomokuni Taniguchi; Yumiko Masaki; Gohzoh Ueda; Chieko Matsumoto; Rieko Sobata; Yasuko Sagara; Hitomi Nakamura; Masahiro Satake; Kiyonori Miura; Naoki Fuchi; Hideaki Masuzaki; Akihiko Okayama; Kazumi Umeki; Yoshihisa Yamano; Tomoo Sato; Masako Iwanaga; Kaoru Uchimaru; Makoto Nakashima; Atae Utsunomiya; Ryuji Kubota; Kenji Ishitsuka; Hiroo Hasegawa; Daisuke Sasaki; Ki-Ryang Koh; Mai Taki; Kisato Nosaka; Masao Ogata; Isao Naruse; Noriaki Kaneko; Sara Okajima; Kenta Tezuka; Emi Ikebe; Sahoko Matsuoka; Kazuo Itabashi; Shigeru Saito; Toshiki Watanabe; Isao Hamaguchi
Journal:  Retrovirology       Date:  2020-08-24       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.